Rue D'Amalfi, Canada

Sheldon N Crane


 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Rue D'Amalfi, CA (2008)
  • Pierrefonds, CA (2008 - 2015)
  • Ile-Perrot, CA (2015 - 2018)

Company Filing History:


Years Active: 2008-2018

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Sheldon N. Crane: Innovator in HIV Protease Inhibitors

Introduction

Sheldon N. Crane is a notable inventor based in Rue D'Amalfi, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. With a total of 9 patents to his name, Crane's work has had a profound impact on the treatment and management of HIV and AIDS.

Latest Patents

Crane's latest patents focus on innovative 2,6-morpholine derivatives and 2,5,6-substituted morpholine derivatives. These inventions are directed towards the inhibition of HIV protease and the replication of HIV. The compounds developed can be utilized in pharmaceutical compositions, potentially in combination with other antivirals, immunomodulators, antibiotics, or vaccines. His work aims to provide methods for the prophylaxis and treatment of HIV infections, as well as to delay the onset or progression of AIDS.

Career Highlights

Throughout his career, Sheldon N. Crane has worked with prominent companies in the pharmaceutical industry, including Merck Canada Inc. and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Crane's notable coworkers include Oscar Miguel Moradei and Vouy Linh Truong. Their collaborative efforts have further advanced the research and development of effective treatments for HIV.

Conclusion

Sheldon N. Crane's innovative work in the field of HIV protease inhibitors showcases his dedication to improving healthcare outcomes for individuals affected by HIV and AIDS. His contributions continue to influence the pharmaceutical landscape and offer hope for better treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…